In the course of our screening program for free radical scavenging substances from microorganisms, which are expected to be useful as therapeutic agents for myocardial and cerebral ischemia1'2^ inflammation3) and other diseases, we have isolated
No takes yet. Share an insight, caveat, or question.
Kato et al. (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: